Stable lenalidomide oral solid preparation

A technology of lenalidomide and solid preparations, which is applied in the field of pharmaceutical preparations, can solve the problems of changing appearance and color, affecting the stability of preparations, and increasing the impurity content of solid oral preparations, achieving improved stability, low impurity content, and high solubility Effect

Active Publication Date: 2010-08-04
NANJING CAVENDISH BIO ENG TECH +1
View PDF4 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Because lenalidomide is insoluble in water, it affects the dissolution rate of its oral solid preparation and then directly affects the bioavailability of the drug. The prior art solves this problem by micronization or strong salt; in addition, the oral solid preparation auxiliary material The type may affect the stability of the preparation. For example, due to the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable lenalidomide oral solid preparation
  • Stable lenalidomide oral solid preparation
  • Stable lenalidomide oral solid preparation

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0082] Example 1

[0083] 5mg lenalidomide capsules

[0084] Premix powder prescription

[0085] Lactose 3000g

[0086] Microcrystalline cellulose 2000g

[0087] 5000g in total

[0088] Attachment: Preparation of adhesive (10% povidone ethanol solution):

[0089] Povidone K30 200g

[0090] Add absolute ethanol to 2000ml

[0091] Capsule prescription

[0092] Lenalidomide 50g

[0093] Premixed accessories 800g

[0094] Croscarmellose Sodium 100g

[0095] 10% povidone ethanol solution 350ml

[0096] Magnesium stearate 10g

[0097] Filled with 10,000 grains

[0098] Preparation:

[0099] (1) Preparation of adhesive Weigh 100g of povidone K30, put it in a 1000ml beaker, add an appropriate amount of absolute ethanol, stir to dissolve, add absolute ethanol to 1000ml, stir well, and set aside.

[0100] (2) Take lactose and microcrystalline cellulose, crush them and pass through a 100-mesh sieve, and mix them evenly according to the prescription of premixed auxiliary materials to obtain premixed auxiliary m...

Example Embodiment

[0109] Example 2

[0110] 10mg lenalidomide capsules

[0111] The premixed powder prescription is the same as in Example 1

[0112] Capsule prescription

[0113] Lenalidomide 100g

[0114] Premixed accessories 750g

[0115] Croscarmellose Sodium 100g

[0116] 10% povidone ethanol solution 350ml

[0117] Magnesium stearate 10g

[0118] Filled with 10,000 grains

[0119] Preparation method: the same as in Example 1.

Example Embodiment

[0120] Example 3

[0121] 25mg lenalidomide capsules

[0122] The premixed powder prescription is the same as in Example 1

[0123] Capsule prescription

[0124] Lenalidomide 250g

[0125] Premixed accessories 600g

[0126] Croscarmellose Sodium 100g

[0127] 10% povidone ethanol solution 350ml

[0128] Magnesium stearate 10g

[0129] Filled with 10,000 grains

[0130] Preparation method: the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a lenalidomide oral solid preparation which is based on 10000 solid preparation units and is prepared by the following components: 10-500g of lenalidomide, 300-1200g of premixed powder, 50-200g of cross-linked sodium carboxymethyl cellulose, 1-50g of magnesium stearate and 100-500ml of 10% (percent weight in volume) povidone absolute ethyl alcohol solution, wherein the premixed powder is the mixture of lactose and microcrystalline cellulose which have the weight ratio of 2:3. In addition, the invention also discloses a preparation method of the lenalidomide oral solid preparation and usage thereof. The lenalidomide oral solid preparation has the advantages that a sample can be reserved for a long time with stable quality; and the lenalidomide oral solid preparation can be released within a short time so as to be easily absorbed by the human body completely.

Description

technical field [0001] The invention relates to pharmaceutical preparation technology, more specifically, relates to an oral pharmaceutical preparation of lenalidomide which is stable, releases quickly in a short period of time and is completely easily absorbed by the human body. Background technique [0002] Lenalidomide, an immunomodulator with antiangiogenic and antineoplastic properties, has the chemical name 3-(4-amino-1-oxo-1,3-dihydro-isoindole-2- Base)-2,6-piperidinedione, its chemical structural formula is as follows: [0003] [0004] Lenalidomide has piperidinedione and indoline residues, and an asymmetric center in the structure, and the currently approved lenalidomide is a racemic compound. [0005] Chinese patent application CN 1239959A (published on December 29, 1999) discloses a chewable tablet containing 75 mg of lenalidomide, and its auxiliary materials include mannose, lactose, talcum powder, glycine, stearic acid, saccharin and 5% Gelatin solution (E...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/00A61K31/454A61K47/38A61P19/08A61P35/00
Inventor 严荣程浩陆洁许永翔
Owner NANJING CAVENDISH BIO ENG TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap